Watch this webinar to learn about the regulatory frameworks and opportunities in the Advanced Therapy market in Japan, including cell therapy, gene therapy, tissue engineering and related products.
The size of ‘cutting edge medicine market’ in Japan is expected to reach 1.85 trillion yen (12.7 billion pounds) in 2025 (+31.7% increase compared to 2016) – according to Fuji Keizai, one of Japan’s leading market research firms.
This content has been restricted to logged in users only. Please login to view this content.
